Anti-CSFV Glycoprotein E2 Antibody (SAA2532) from ProteoGenix; catalogue ARO-A22981; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The Anti-CSFV Glycoprotein E2 Antibody (SAA2532) is a highly specific and sensitive tool for the detection and inhibition of the glycoprotein E2 of the Classical Swine Fever Virus (CSFV). This glycoprotein is crucial for the virus to enter and infect host cells, making it an ideal target for neutralization and prevention of viral spread.
This antibody is primarily used for research purposes in the field of veterinary medicine, specifically for the study of CSFV and its interactions with host cells. It can also be used in diagnostic assays for the detection of CSFV in infected animals, as well as in the development of vaccines and therapeutics against the virus.
The Anti-CSFV Glycoprotein E2 Antibody (SAA2532) has been successfully used in various experimental settings, including ELISA, Western blot, and immunofluorescence assays. It has shown high specificity and sensitivity in detecting CSFV in samples from infected animals, as well as in inhibiting viral entry and replication in cell culture models.
In addition, this antibody has been used in in vivo studies to evaluate its potential as a therapeutic agent for CSFV infection. Results have shown a significant reduction in viral load and improved survival rates in animals treated with this antibody.
Keywords: Anti-CSFV Glycoprotein E2 Antibody, SAA2532, Classical Swine Fever Virus, glycoprotein E2, neutralization, prevention, research, veterinary medicine, diagnostic assays, vaccines, therapeutics, ELISA, Western blot, immunofluorescence, specificity, sensitivity, viral entry, replication, in vivo studies, therapeutic agent, viral load, survival rates.
ProteoGenix catalogue number ARO-A22981. For research use only.
Target: Autoprotease p20, Capsid protein C, Cysteine protease NS2, E(rns) glycoprotein, EC:2.7.7.48, EC:3.4.21.113, EC:3.4.22.-, EC:3.6.1.15, EC:3.6.4.13, Envelope glycoprotein E1, Envelope glycoprotein E2, Genome polyprotein, N-pro, N-terminal protease, NS2-3, NS4A, NS4B, NS5A, NS5B, Non-structural protein 2, Non-structural protein 2-3, Non-structural protein 3, Non-structural protein 4A, Non-structural protein 4B, Non-structural protein 5A, RNA-directed RNA polymerase, Serine protease NS3, Viroporin p7, gp33, gp44/48, gp55; Clonality: Monoclonal Antibody; Applications: ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA |
|---|---|---|---|---|---|---|---|---|
| Autoprotease p20, Capsid protein C, Cysteine protease NS2, E(rns) glycoprotein, EC |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
